Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890818) titled 'Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: University of Cincinnati
Condition:
Type 2 Diabetes
Intervention:
Device: Continuous glucose monitor
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: November 2026
Target Sample Size: 218
Countries of Recruitment:
United States
To know more, visit https://clini...